Lantern Pharma, Inc. (LTRN)
3.09
+0.09
(+3.00%)
USD |
NASDAQ |
May 19, 16:00
3.08
-0.01
(-0.32%)
After-Hours: 20:00
Lantern Pharma EPS Diluted (TTM) : -1.445 for March 31, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| BioVie, Inc. | -4.272 |
| Vertex Pharmaceuticals, Inc. | 16.87 |
| Spero Therapeutics, Inc. | 0.2436 |
| Replimune Group, Inc. | -3.582 |
| Acurx Pharmaceuticals, Inc. | -4.404 |